Ricerca live
TopFind sta recuperando le corrispondenze piu recenti per la tua ricerca.
Abbiamo esaminato 6 risultati live per herzuma e li abbiamo ridotti alle 3 opzioni che sembrano piu utili da confrontare per prime.
I temi piu forti in questa lista sono Oncology e Biosimilar.
Fonte: Celltrion Healthcare Philippines Inc.
Descrizione
Herzuma is a biosimilar used in the treatment of HER2-positive cancers, providing a high-quality alternative to reference biologics.
Ideale per
HER2 Positive cancer, Oncology therapy e Biosimilar oncology
Valutazione
Fonte: Celltrion Healthcare Singapore Private Limited
Descrizione
Herzuma is a trastuzumab biosimilar referencing Herceptin, registered in Singapore for treating HER2-positive breast and gastric cancers. It provides a clinically comparable treatment option that is supported by local health subsidies.
Ideale per
HER2 Positive cancer care, Breast cancer patients e Affordable trastuzumab access
Valutazione
Fonte: Celltrion Healthcare
Descrizione
Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials.
Ideale per
HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy e Oncology infusion treatment
Valutazione
| Confronta | Herzuma (Trastuzumab) | Herzuma | Herzuma (Trastuzumab) |
|---|---|---|---|
| Fonte | Celltrion Healthcare Philippines Inc. | Celltrion Healthcare Singapore Private Limited | Celltrion Healthcare |
| Descrizione | Herzuma is a biosimilar used in the treatment of HER2-positive cancers, providing a high-quality alternative to reference biologics. | Herzuma is a trastuzumab biosimilar referencing Herceptin, registered in Singapore for treating HER2-positive breast and gastric cancers. It provides a clinically comparable treatment option that is supported by local health subsidies. | Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials. |
| Ideale per | HER2 Positive cancer, Oncology therapy e Biosimilar oncology | HER2 Positive cancer care, Breast cancer patients e Affordable trastuzumab access | HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy e Oncology infusion treatment |
| Azione | |||
| Valutazione |
Se vuoi iniziare dall'opzione piu equilibrata, ti consiglio:
"Herzuma (Trastuzumab) da Celltrion Healthcare Philippines Inc.."
L'ho scelto perche Herzuma offers a clinically validated biosimilar option for patients with HER2-positive oncological conditions.